The Capitol Forum

@capitolforum.bsky.social

News & analysis informing policymakers, investors, and industry stakeholders on policy's impact on market competition Send tips to tips@thecapitolforum.com.

(1/2) Health Care Weekly: Corcept Seeks Dismissal of Off-Label Marketing Whistleblower Suit; Medicare ACCESS Program to Cover More Chronic Conditions; FDA Launches Accelerated Investigational Drug Review Program; Agencies Announce Fresh Steps to Curb Animal Testing; +

(1/2) Antitrust Agenda: Minnesota AG Announces Investigation into Fertilizer Industry; Adam Candeub's Written Responses to Judiciary Committee Questions; Institutional Investor Common Ownership of Competitors is a Plus Factor, District Court Finds; +

(1/2) Financials Friday: Enova Abandons Federal Banking Charter; Warren Pitches Reviving Crypto Bill in a Democratic Congress; Senate Advances Trump's CFPB Nominee; Corpay Agrees to $100 Million Deceptive Practices Fine; +

(1/2) Chemed: Families of VITAS Patients Say The Company Mismanaged the Care of Their Loved Ones, Causing Physical and Emotional Pain; Former Employees Say VITAS Misrepresented Services When Marketing and Left Patients Alone in Crises; +

(1/2) Labor Weekly: Trump Administration's Embattled Ban on Non-Citizen Truck Drivers Could Eliminate 200,000 Drivers, Squeezing Truck Load Capacity; Bill Granting Broad NCAA Antitrust Immunity Teed Up for Senate Vote; +

(1/2) Health Care Weekly: FDA Leaders Open to Regulatory Flexibility on Psychedelics; House E&C Panel May Back Medicare Coverage for Respiratory Illness Care at Pharmacies; Patients, Plans Push for No Surprises Act Dispute Resolution Changes; +